key: cord-0915870-qeabzbkp
authors: Patani, Henna; Sukhija-Cohen, Adam; Klausner, Jeffrey D; Engeran, Whitney; Weinstein, Michael
title: Disseminated gonococcal infection: a potential marker of failing sexually transmitted infection control and prevention services
date: 2021-07-27
journal: Sex Transm Infect
DOI: 10.1136/sextrans-2021-055149
sha: 258303fee2b67108e03a5ad8be0b3827d482a4cf
doc_id: 915870
cord_uid: qeabzbkp

nan

The SARS-CoV-2 (COVID-19) pandemic has affected routine STI testing leading to undiagnosed and untreated infections, 1 a new obstacle among a series of issues related to STI control in the USA. 2 In November 2020, the California Department of Public Health's (CDPH) cited reports of disseminated gonococcal infection (DGI) as a result of "… people not seeking care or getting routine testing during the COVID-19 pandemic". 1 AIDS Healthcare Foundation (AHF)-a non-profit organisation providing free walk-in STI servicesconducted a retrospective cohort review of all patients who tested gonorrhoea positive at its four California clinics in Los Angeles, Long Beach and Oakland in October 2020. As per CDPH recommendations for monitoring DGI, positive gonorrhoea cases were checked for reported symptoms at the time of their gonorrhoea test visit including fever, joint pain, swelling of joints, or skin lesions. 3 Among 214 patients who tested gonorrhoea positive (196 (92%) male; 118 (55%) aged 25-34 years), 28 (13%) were identified as potential DGI cases based on symptoms documented in the medical record or failure to return for follow-up treatment. Of the 28, four had reported a skin rash and one reported having fever, muscle pain and lower right abdominal pain. All 28 patients were contacted by phone and through AHF's online patient portal for additional information about symptoms 7 days prior to their gonorrhoea test date. No case-patient recalled any symptoms of DGI.

CDPH released another DGIfocused press release February 2021, citing homelessness and/or the use of illicit drugs as risk factors for DGI. 4 Although no cases among AHF patients were found in this retrospective cohort review, continued efforts are needed to ensure vulnerable populations can access gonorrhoea testing and timely treatment services during and beyond the COVID-19 pandemic.

California sees an increase in rare, severe complications from untreated gonorrhea (CDPH website)

From control to crisis: the resurgence of sexually transmitted diseases

CDPH information: increasing disseminated gonococcal infections in California -resources including a webinar on 2/23/21 (Los Angeles County public health website